Tag : RESECTABLE ESOPHAGEAL ADENOCARCINOMA

The incidence of esophageal adenocarcinoma (EAC) is increasing, particularly in high-income countries, with almost 86,000 new cases globally in 2020. While surgery is the mainstay for cure in non-metastatic disease, multimodality treatment can improve survival in these patients.